Researchers unveil TSC22D3 as a novel prognostic biomarker in AML
Dec. 16, 2022
TSC22 domain family member 3 (TSC22D3) is a glucocorticoid-induced gene that plays a key regulatory role in immunosuppression and cell proliferation. Its prognostic usefulness in acute myeloid leukemia (AML) has not been deeply investigated yet.